Literature DB >> 29576240

Question 1: Why do children still die from asthma?

Ana Maria Herrera1, Dominic A Fitzgerald2.   

Abstract

Asthma is one of the commonest chronic conditions in children and can occasionally be fatal. Little has changed regarding the risk factors for children dying from asthma in the last 30 years. The majority of deaths from asthma occur in children from socio-economically disadvantaged backgrounds. These should be preventable with better education of families, oversight of medication adherence and improved communication between health care professionals and families. More needs to be done to deliver basic messages more effectively about asthma management to the most vulnerable in communities around the world.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Children; Death; Modifiable risk factors

Mesh:

Year:  2018        PMID: 29576240     DOI: 10.1016/j.prrv.2018.02.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  4 in total

1.  Tumor-derived MDSCs inhibit airway remodeling in asthmatic mice through regulating IL-10 and IL-12.

Authors:  Yanli Zhang; Boyi Xu; Bin Luan; Yan Zhang; Xiufang Wang; Xiaorong Xiong; Hongke Shi
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

2.  Rabbit plasma metabolomic analysis of Nitroproston®: a multi target natural prostaglandin based-drug.

Authors:  Ksenia Shestakova; Alex Brito; Natalia V Mesonzhnik; Natalia E Moskaleva; Ksenia O Kurynina; Natalia M Grestskaya; Igor V Serkov; Igor I Lyubimov; Vladimir V Bezuglov; Svetlana A Appolonova
Journal:  Metabolomics       Date:  2018-08-20       Impact factor: 4.290

3.  Prominent Bronchopulmonary Vascular Anastomoses in Fatal Childhood Asthma.

Authors:  Csaba Galambos; Melissa L Bates; Douglas Bush; Steven H Abman
Journal:  Ann Am Thorac Soc       Date:  2018-11

4.  Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study.

Authors:  A M Herrera; P Brand; G Cavada; A Koppmann; M Rivas; J Mackenney; H Sepúlveda; M E Wevar; L Cruzat; S Soto; M A Pérez; A León; I Contreras; C Alvarez; B Walker; C Flores; V Lezana; C Garrido; M E Herrera; A Rojas; C Andrades; E Chala; R A Martínez; M Vega; J A Perillán; H Seguel; I Przybyzsweski
Journal:  Allergol Immunopathol (Madr)       Date:  2018-12-27       Impact factor: 1.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.